Literature DB >> 19763953

Analysis of SUMOylation of topoisomerase IIalpha with Xenopus egg extracts.

Yoshiaki Azuma1.   

Abstract

Posttranslational protein modification by the Small Ubiquitin-like MOdifiers (SUMO) is involved in many cellular functions including organization of nuclear structures and chromatin, transcriptional regulation, and nucleo-cytoplasmic transport. Both genetic and biochemical studies indicate that the SUMO modification pathway plays an important role in proper cell cycle control, especially in the normal progression of mitosis. DNA topoisomerase II has been shown to be modified by SUMO in budding yeast as well as in vertebrates. We have shown by biochemical analysis using the Xenopus egg extract (XEE) cell-free assay system that DNA topoisomerase IIalpha (Topo IIalpha) is modified by SUMO-2/3 on mitotic chromosomes in the early stages of mitosis. Inhibition of mitotic SUMOylation in the XEE assay system causes aberrant sister chromatid separation in anaphase and alters Topo IIalpha association with chromosomes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19763953      PMCID: PMC3703827          DOI: 10.1007/978-1-60761-340-4_17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  19 in total

Review 1.  Protein modification by SUMO.

Authors:  Erica S Johnson
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

Review 2.  SUMO: a history of modification.

Authors:  Ronald T Hay
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

Review 3.  Basic mechanism of eukaryotic chromosome segregation.

Authors:  Mitsuhiro Yanagida
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-03-29       Impact factor: 6.237

Review 4.  Modification in reverse: the SUMO proteases.

Authors:  Debaditya Mukhopadhyay; Mary Dasso
Journal:  Trends Biochem Sci       Date:  2007-05-17       Impact factor: 13.807

5.  Chromosome assembly in vitro: topoisomerase II is required for condensation.

Authors:  Y Adachi; M Luke; U K Laemmli
Journal:  Cell       Date:  1991-01-11       Impact factor: 41.582

6.  Conjugation of human topoisomerase 2 alpha with small ubiquitin-like modifiers 2/3 in response to topoisomerase inhibitors: cell cycle stage and chromosome domain specificity.

Authors:  Marta Agostinho; Vera Santos; Fernando Ferreira; Rafael Costa; Joana Cardoso; Inês Pinheiro; José Rino; Ellis Jaffray; Ronald T Hay; João Ferreira
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

7.  SIZ1/SIZ2 control of chromosome transmission fidelity is mediated by the sumoylation of topoisomerase II.

Authors:  Yoshimitsu Takahashi; Vladimir Yong-Gonzalez; Yoshiko Kikuchi; Alexander Strunnikov
Journal:  Genetics       Date:  2005-10-03       Impact factor: 4.562

8.  Isolation of type I and II DNA topoisomerase mutants from fission yeast: single and double mutants show different phenotypes in cell growth and chromatin organization.

Authors:  T Uemura; M Yanagida
Journal:  EMBO J       Date:  1984-08       Impact factor: 11.598

9.  Emerging roles of the SUMO pathway in mitosis.

Authors:  Mary Dasso
Journal:  Cell Div       Date:  2008-01-24       Impact factor: 5.130

10.  SUMO-2/3 regulates topoisomerase II in mitosis.

Authors:  Yoshiaki Azuma; Alexei Arnaoutov; Mary Dasso
Journal:  J Cell Biol       Date:  2003-11-03       Impact factor: 10.539

View more
  7 in total

1.  Rod/Zw10 complex is required for PIASy-dependent centromeric SUMOylation.

Authors:  Hyunju Ryu; Yoshiaki Azuma
Journal:  J Biol Chem       Date:  2010-08-09       Impact factor: 5.157

2.  SUMOylation of the C-terminal domain of DNA topoisomerase IIα regulates the centromeric localization of Claspin.

Authors:  Hyunju Ryu; Makoto M Yoshida; Vinidhra Sridharan; Akiko Kumagai; William G Dunphy; Mary Dasso; Yoshiaki Azuma
Journal:  Cell Cycle       Date:  2015-07-01       Impact factor: 4.534

3.  A single Drosophila embryo extract for the study of mitosis ex vivo.

Authors:  Ivo A Telley; Imre Gáspár; Anne Ephrussi; Thomas Surrey
Journal:  Nat Protoc       Date:  2013-01-17       Impact factor: 13.491

4.  SUMOylation of Psmd1 controls Adrm1 interaction with the proteasome.

Authors:  Hyunju Ryu; Steven P Gygi; Yoshiaki Azuma; Alexei Arnaoutov; Mary Dasso
Journal:  Cell Rep       Date:  2014-06-05       Impact factor: 9.423

5.  PIASy-dependent SUMOylation regulates DNA topoisomerase IIalpha activity.

Authors:  Hyunju Ryu; Maiko Furuta; Donald Kirkpatrick; Steven P Gygi; Yoshiaki Azuma
Journal:  J Cell Biol       Date:  2010-11-15       Impact factor: 10.539

Review 6.  Topoisomerase IIα in chromosome instability and personalized cancer therapy.

Authors:  T Chen; Y Sun; P Ji; S Kopetz; W Zhang
Journal:  Oncogene       Date:  2014-10-20       Impact factor: 9.867

7.  SUMOylation of DNA topoisomerase IIα regulates histone H3 kinase Haspin and H3 phosphorylation in mitosis.

Authors:  Makoto M Yoshida; Lily Ting; Steven P Gygi; Yoshiaki Azuma
Journal:  J Cell Biol       Date:  2016-06-20       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.